Forgot Password.
By Logging in, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Not a member? Sign Up
By Signing up, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Have an account? Log in
Back to Login? Log in
By registering in, you are agreeing to the MedSearch Global terms and condition and Privacy Policy.
Thinking of joining a study?
Register your interest
7952 results
Interventional
Not Applicable
80
Immediate Autoimmune Intervention Mastery Course (AIM)
Immediate Question and Answer sessions. (AIM Q and A sessions)
Delayed Autoimmune Intervention Mastery Course (delayed AIM course)
Delayed AIM Question and Answer sessions
Terry L. Wahls
Source: clinicaltrials.gov
Phase2
43
Nivolumab
Ipilimumab
Carboplatin
Cabazitaxel
Andrew J. Armstrong, MD
Phase1
22
Ziftomen's
Venetoclax
Azacitidine
M.D. Anderson Cancer Center
Observational
4900
No intervention
Columbia University
Phase3
288
Ryz101
Everolimus
Sunitinib
Octreotide
Lanreotide
RayzeBio, Inc.
32
Biospecimen Collection
Computed Tomography
Osimertinib
Positron Emission Tomography
Stereotactic Body Radiation Therapy
Survey Administration
City of Hope Medical Center
75
Abiraterone
Darolutami
Prednisone
Mamta Parikh
37
Pembrolizumab
110
U101
Eutilex
200
Agent Affecting Integumentary System
Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment
Quality-of-Life Assessment
Administration questionnaire